Stevenage, UK, 18 November 2013. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that a further family of patents, offering additional protection of its proprietary cell culture technology, Combinatorial Cell Culturea , have been granted by the US Patent Office, ... (more)
http://www.biospace.com/news_story.aspx?StoryID=316054&full=1
http://www.biospace.com/news_story.aspx?StoryID=316054&full=1
No comments:
Post a Comment